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Abstract
Background: Injecting drug use is an increasingly important cause of HIV transmission in most countries 
worldwide, especially in eastern Europe, South America, and east and southeast Asia. Among people actively 
injecting drugs, provision of clean needles and opioid substitution reduce HIV-transmission. However, former 
injecting drug users (fIDUs) are often overlooked as a high risk group for HIV transmission. We compared HIV risk 
behavior among current and former injecting drug users (IDUs) in Indonesia, which has a rapidly growing HIV- 
epidemic largely driven by injecting drug use.
Methods: Current and former IDUs were recruited by respondent driven sampling in an urban setting in Java, and 
interviewed regarding drug use and HIV risk behavior using the European Addiction Severity Index and the Blood 
Borne Virus Transmission Questionnaire. Drug use and HIV transmission risk behavior were compared between 
current IDUs and former IDUs, using the Mann-Whitney and Pearson Chi-square test.
Results: Ninety-two out of 210 participants (44%) were self reported former IDUs. Risk behavior related to sex, 
tattooing or piercing was common among current as well as former IDUs, 13% of former IDUs were still exposed 
to contaminated injecting equipment. HIV-infection was high among former (66%) and current (60%) IDUs. 
Conclusion: Former IDUs may contribute significantly to the HIV-epidemic in Indonesia, and HIV-prevention should 
therefore also target this group, addressing sexual and other risk behavior.
Background
Worldwide, injecting drug use is estimated to account 
for just less than one-third of new infections outside 
sub-Saharan Africa [1]. HIV-prevention programs for 
injecting drug users (IDUs) therefore put emphasis on 
people actively injecting drugs, especially through needle 
exchange or opioid replacement. Besides active IDUs, 
people who have a previous history of injecting drug use 
(former IDUs) are probably also an im portant risk 
group for HIV transmission. However, relatively little is 
known about this group. Sporadic studies from western 
countries have shown that former IDUs (fIDUs) may 
have a high risk of becoming HIV-infected or spreading
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HIV to others [2,3]. To our knowledge, no studies on 
fIDUs have been reported from low- or middle-income 
countries.
Injecting drug use increased dramatically in the late 
'90s in Indonesia, acting as the main force driving the 
HIV-epidemic. Among the general population, the pre­
valence of HIV-infection is still low (0.3%), but up to 
50% or more of IDUs are already HIV-infected [4]. Drug 
use is illegal in Indonesia, and harm  reduction pro­
grams, although officially supported by the Indonesian 
government, only reach a minority of IDUs. Apart from 
sharing needles, sexual risk behavior is also common 
among drug users [5]. In three large cities in Indonesia, 
over two thirds of IDUs were sexually active, of whom 
many reported having multiple partners (48%) and sex 
with female sex workers (40%) in the preceding year.
© 2010 Iskandar et al; licensee BioMed Central Ltd. This is an O pen Access article distributed under the term s o f the Creative C om m ons B io  Med Central Attribution License ( http://creativecom m ons.org/licenses/by/2.0), w hich  perm its unrestricted use, distribution, and reproduction in 
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Consistent condom use was only reported by 10% of 
sexually active IDUs [5].
We know of no reported data concerning HIV risk 
behavior among fIDUs in Indonesia, and fIDUs receive 
very little attention in current prevention programs in 
general. This may seriously limit the success of HIV- 
prevention focusing on drug injection, as a considerable 
number of IDUs change from injection to non-injection 
drug administration or completely abstain from illicit 
drug use [6]. The prevalence of HIV may be high in 
fIDUs. Transmission of blood borne viruses may con­
tinue to occur through sexual behavior and/or by con­
tam inating equipm ent that is subsequently used by 
others for drug use, tattooing and/or piercing [2,7,8].
Furthermore, fIDUs may also play an important role 
in transmitting HIV infections to the general population 
because, compared with current IDUs (cIDUs), fIDUs 
have more sexual contact with people who do not use 
drugs [9,10]. Hopefully, a better characterization of for­
mer IDUs may contribute to improve HIV-prevention. 
Therefore, the aim of the present study was to explore 
the characteristics and the risk behavior of former IDUs 
in Indonesia in comparison with current IDUs.
Methods
Setting and patients
From June to September 2008, 210 IDUs were recruited 
in Bandung, the capital of West-Java and epicenter of 
the epidemic of injecting drug use in Indonesia. Respon­
dent driven sampling, a form of peer recruitment, was 
used for recruitment of IDUs from the community [11]. 
W ith help from local non-governmental organizations 
involved in outreach to IDUs, three cIDUs and three 
fIDUs from different parts of Bandung were selected to 
act as 'seeds' for RDS and invited to a community clinic 
which has a specific program for IDUs. Following their 
inclusion in the study, these six seeds were asked to 
recruit two other persons injecting drugs, either in the 
last six months (cIDUs) or longer ago (fIDU), by giving 
individually numbered coupons. IDUs presenting at the 
community clinic with the coupons, were asked them ­
selves to recruit two other (current or former) IDUs. 
This process of recruitment continued until the desired 
sample size was achieved. Numerical simulations have 
shown that respondent driven sampling estimates con­
verge to the true values even if the seeds are not drawn 
as desired [12].
As a part of the RDS process, an incentive was offered 
for participating in the interview ($3) and for recruiting 
two injecting drug using peers ($2 per eligible peer 
recruited). After the initial seeds were recruited, only 
those people who presented coupons were permitted to 
participate in the study. The study was completely anon­
ymous, but to prevent the same participant from
entering the study twice, physical marks such as tattoos, 
scars, or birth marks were recorded.
Only those candidates who were or had previously 
been IDUs were eligible to be included in the study. 
Two outreach workers from non-governmental harm 
reduction organizations, both with a previous history of 
drug use, confirmed that the respondents were indeed 
IDUs. To this purpose they looked for possible needle 
tracks, asked each respondent to demonstrate how he/ 
she injected drugs, and to clarify specific 'slang' used by 
IDUs. All IDUs who passed this screening then provided 
informed consent. The study was approved by the regio­
nal medical-ethical committee (The Health Research 
Ethics Committee, Faculty of Medicine, Padjadjaran 
University/Dr. Hasan Sadikin General Hospital Ban­
dung) and conducted within the context of program on 
prevention and treatm ent of HIV in the context of 
injecting drug use in Indonesia [13].
Assessment
The interview was done at the community health center 
by trained interviewers who assured all participants that 
their anonymity would be strictly maintained. All parti­
cipants who completed the interview session received a 
coupon for free HIV, HBV, HCV and syphilis testing at 
Hasan Sadikin hospital, Bandung. If found positive for 
HIV, participants were offered CD4-cell counts, chest 
X-ray and if needed, antiretroviral and/or syphilis treat­
ment, all free of charge.
The interviewers used two validated questionnaires: 
the European Addiction Severity Index (EuropASI) and 
the Blood Borne Virus Transmission Questionnaires 
(BBV-TRAQ). The EuropASI is an adaptation of the 
Addiction Severity Index (fifth version). It is a semi­
structured interview which takes about one hour, cover­
ing issues that may contribute to patients' substance- 
abuse problems, such as medical status, employment/ 
support status, drug/alcohol use, legal status, family 
social relationship, and psychiatric problems [14]. Parti­
cipants are asked if they ever used a number of listed 
drugs regularly (more than 3 times or 2 consecutive 
days a week). For regularly used drugs, further informa­
tion is recorded including the first time the particular 
drug was used, the duration of use in a life time, the fre­
quency of drug use in the previous 30 days, and drug 
route of administration [14]. ASI has shown excellent 
reliability and validity across a range of types of patients 
and treatment settings in many countries [15]. For the 
translation into Bahasa Indonesia, W H O  translation 
procedures were used [16].
The BBV-TRAQ questionnaire assesses how often 
injecting drug users participate in specific injecting, sex­
ual and other risk-practices that may expose them to 
blood-borne viruses. The instrum ent consists of
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34 questions divided in three sub-scales which measure 
frequency of current risk behavior related to blood to 
blood transfer (20 questions); sexual practices (8 ques­
tions); and other skin penetration activities (6 questions) 
in the previous month. W ith respect to possible blood 
to blood transfer, information is collected about contact 
with contam inated needles and syringes, other drug 
injecting equipment sharing and involvement of other 
people in the drug preparation and injecting process. 
Questions related to sexual risk behavior address unpro­
tected vaginal, anal, oral, and manual sex with other 
people, with or without lubricant, and during menstrua­
tion or not. O ther questions address skin penetration 
risk behavior (tattooing and piercing), and shared use of 
toothbrush, razor, and personal hygiene equipment. The 
administration time for the instrument is short (around 
15 minutes), and it has been shown good reliability and 
validity [17,18].
Data analysis and statistics
A form er IDU (fIDU) was defined as a person who 
reported to have injected an illicit drug at some point in 
his/her life, but not to have injected any drugs in the six 
months prior to the interview (17, 18). A current IDU 
(cIDU) was defined as a person who reported that he/ 
she had injected any type of illicit drug in the six 
months prior to the interview [6,10]. Data were analyzed 
both descriptively and inferentially. Descriptive data are 
presented in terms of percentage, mean, and standard 
deviation. Subjects engaging in at least one risk taking 
behavior in a subscale of the BBV-TRAQ were regarded 
as taking risks in that domain. Data were analyzed infer­
entially for differences between fIDUs and cIDUs. Pear­
son Chi-Square was used for dichotomous data and the 
Mann-Whitney test for non-parametric continuous data. 
All tests were two-sided, with a P-value of 0.05 or less 
considered to indicate statistical significance. Analyses 
were performed with the use of SPSS, version 11.5.
Results
Characteristics of IDUs in Bandung
A total of 210 IDUs were recruited, of whom 194 were 
men (92%), 92 were fIDUs (44%), and 118 were cIDUs 
(56%). Thirty-three out of 92 fIDUs (35.9%) were invited 
by cIDUs, while 34 of 118 cIDUs (30.3%) were invited 
by fIDUs, showing extensive social linking between the 
two groups. Most of the demographic characteristics of 
fIDUs and cIDUs did not differ, except for the length of 
injecting drug and percentage of those who developed 
AIDS (table 1). The mean age was 28 (±4) years and 
most participants had graduated from senior high school 
and had been employed at some point in the last 3years. 
They had started using drugs at a young age (14 (± 3) 
years). Injection of drugs had typically started 4 years
after non-injecting drug administration, and the period 
of injecting drugs averaged 7 (± 4) years. Three quarters 
of the participants had been tested for HIV and among 
those tested 63% reported to be HIV-infected. There 
was no significant association between the cumulative 
years of drug injecting and HIV-status (P = 0.47). One 
third of those who were HIV-infected reported to have 
developed AIDS. Although cIDUs had injected for a 
longer period than fIDUs, HIV-infected individuals in 
the latter group more commonly reported having AIDS 
(44% vs 18%; P = 0,01).
The most used substance by all participants was her­
oin. Ninety four percent of the total participants had at 
some point used heroin regularly (at least three times a 
week or for two consecutive days in a week for more 
than 6 months). The other most used substances were 
cannabis, benzodiazepines, and alcohol. More than three 
quarters of participants had ever used or still used dif­
ferent drugs at the same time (poly drug use) and 70% 
of the total IDUs had ever used or still used ampheta­
mine or methamphetamine regularly (median 2 years 
(range less than 1 year until 15 years).
In the last 30 days, cIDUs had typically used more 
drugs than fIDUs but neither cIDUs nor fIDUs reported 
total abstinence in the last 30 days. The most used sub­
stances by fIDUs in the last 30 days were alcohol, licit 
or illicit methadone/buprenorphine while cIDUs mostly 
used licit or illicit methadone/buprenorphine, heroin, 
benzodiazepines, and cannabis (table 2). Licit or illicit 
use of methadone or buprenorphin cannot be differen­
tiated with the ASI.
Risk behavior related to transmission of blood-borne 
viruses
Blood to blood transfer risk behavior was reported by 
76% of cIDUs and 13% of fIDUs (X2 = 82,73; p < 0,01) 
(table 3). Risk behavior of ninety cIDUs (76%) was 
related to sharing of contam inated drug injecting 
equipm ent. C urrent IDUs often reported  behavior 
associated with a very high risk of transm ission of 
blood-borne pathogens, including injecting with 
another person's used needle or syringe (reported by 
15% of cIDUs), re-use of a needle or syringe taken out 
of a shared disposal/sharps container w ithout using 
bleaching (9%), and sharp injuries from another per­
son's used needle/syringe (15%). cIDUs also reported 
behavior associated with a som ewhat lower risk of 
transmission. For example, they had exposure to con­
taminated drug injecting equipment included shared 
use of a tourniquet (43%); injecting a drug prepared 
with water previously used by another person (41%); 
handling another person's used needle or syringe when 
wounded at his or her hand (34%); wiping his/her own 
injection site with an object that had been used by
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Table 1 Sociodemographic characteristics of former and current injecting drug users
To ta l g ro u p  (N =  210) fID U s (N =  92) cID U s (N =  118) P
Age, mean 27,8 (3,8) 28,1 (4,0) 27,5 (3,8) 0,64
Male gender 92% 89% 95% 0,12
D rug use 0,35
A g e  of first drug use, mean 14,0 (2,8) 14,2 (3,3) 13,8 (2,2) 0,31
A g e  of first drug injection, mean 18,0 (3,1) 18,4 (3,1) 17,8 (3,1) 0,17
Years o f injecting in life time, mean 7,1 (3,8) 5,5 (3,6) 8,4 (3,4) <  0,01
Marital Status 0,35
Married/remarried 30% 36% 25%
W idow ed 2% 3% 2%
Separated/divorced 11% 6% 14%
Never married 57% 55% 59%
Em ploym ent in the past 3 years 0,13
Full tim e 41% 48% 36%
Part-time 37% 36% 39%
Student 5% 5% 4%
Unem ployed or housew ife 17% 11% 21%
Education 0,48
Ju nior high s c h o o lo r  less 6% 4% 7%
Senior high school 87% 87% 87%
Undergraduate or higher 7% 7% 6%
HIV-AIDS
Ever HIV-tested 75% 71% 78% 0,23
HIV-infected# 63% 66% 60% 0,47
Have developed AIDS## 30% 44% 18% 0,01
All data are presented in percentage unless stated otherwise
# n = 145; no data available for 12 subjects; ## n = 83; no data for 8 HIV-positive subjects
another person (27%); touching his/her own injection sucking or licking and other handling of another per-
site soon after 'assisting' another person with their son's used needle/syringe. Interestingly, benzodiazepine
injection (26%); and injecting a drug that was prepared use was more common among IDUs engaging in risky
immediately after 'assisting' another person with their injecting behavior, 56% vs. 39% among cIDUs (X =
injection but without washing hands between activities 2,26; P = 0,19) and fIDUs (33% vs 9%; X2 = 5,99; P =
(26%). While fIDUs did not inject anymore, 13% still 0,03). Injecting risk behavior was not associated with
had some risk of blood borne pathogens transmission, use of alcohol, cannabis or m ethadone/buprenorphin
especially through accidental needle stick injuries and (data not shown).
Table 2 Drug use among former and current injecting drug users
K in d  o f  d ru g  # Life  tim e d ru g  use D ru g  u se  in last 3 0  d a y s
f ID U s  (n =  92) c ID U s  (n =  118) P fID U s (n = 92) c ID U s  (n = 118) P
An y use o f a l c o h o l 9 1 % 9 7 % 0,14 42% 59% 0,03
Alcohol, over threshold ## 66% 70% 0,66 26% 42% 0,02
Heroin 99% 100% 0,44 0% 79% <  0,01
M ethadone or buprenorphine 33% 65% <0 ,0 1  12% 53% <  0,01
O ther opiates 22% 23% 0,87 1% 5% 0,14
Benzodiazepines 66% 79% 0,06 12% 52% <  0,01
A m ph etam ine 52% 53% 0,89 1% 9% 0,03
Cannab is 84% 87% 0,55 13% 47% <  0,01
Ecstasy (M DMA) 44% 37% 0,40 9% 14% 0,28
More than one substance 78% 83% 0,38 12% 55% <  0,01
# regular use (more than 3 times or 2 consecutive days a week)' ## > 3 drinks in 1-2 hours, > 3 times or 2 consecutive days a week. 
Note: Less than three participants used inhalant, hallucinogens or cocaine in the last 30 days.
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Table 3 Risk behavior among former (fIDUs) and current injecting drug users (cIDUs) in the last 30 days
R isk  B eh av io r fID U s  
(N =  92)
cID U s  
(N =  118)
X 2 P
Blood-blood transfer, n (%) 13% 76% 82,73 <0,01
Suck or lick a filter w hich had been used by another person 4% 14% 5,81 0,02
Inject a drug prepared w ith water w hich had been used by another person 0% 41% 45,30 <0,01
Been injected by another person w ho had already injected or assisted in som eon e else's injection 0% 20% 21,13 <0,01
Receive an accidenta lneed le-stick/p rick  from  another person's used needle/syringe 3% 15% 7,56 <0,01
Re-use a needle/syringe taken out of a shared disposal/sharps container 0% 9% 8,26 <0,01
S e x u a lr isk  behavior, n (%) 42% 56% 3,57 0,06
Engage in unprotected v a g in a ls e x  with another person 35% 47% 2,98 0,08
Engage in unprotected v a g in a ls e x  with another person during m enstruation 11% 20% 2,90 0,09
Engage in unprotected a n a ls e x  w ith another person 7% 8% 0,10 0,76
Tattoo or piercing, n (%) 52% 53% 0,02 0,90
Tattooed by som eon e w ho was not a professionaltattooist 4% 15% 6,56 <0,01
Been pierced by som eon e w ho  w as not a p rofessionalp iercer 10% 14% 0,96 0,327
Use another person's toothbrush 3% 14% 7,45 <0,01
Sexual risk behavior of some form was reported by 
56% of cIDUs and 42% of fIDUs (X2 = 3,57; P = 0,06). 
The most common sexual risk behavior for cIDUs and 
fIDUs was unprotected vaginal sex (47% respectively 
35%, NS); reported unprotected anal sex was much 
lower (8% respectively 7%, NS). No statistical significant 
differences were found between former and current 
IDUs regarding oral and manual sex (data not shown). 
Excessive alcohol use was more common in IDUs enga­
ging in risky sexual behavior, both among cIDUs (51% 
vs 33%; X2 = 3,86; P = 0,06) and fIDUs (46% vs 11%; 
X2 = 14,14; P < 0.01). Other risk behavior such as tat­
tooing and piercing, which confer a much lower risk of 
HIV transm ission com pared to needle-sharing, was 
reported by half of all respondents (52% of fIDUs and 
53% of cIDUs).
Discussion
This cross-sectional study from Indonesia shows a high 
prevalence of HIV-infection among relatively young and 
well-educated former and current IDUs. Current IDUs 
obviously had much higher risks of viral transmission 
related to injecting drugs, but also former IDUs had 
risks related to blood to blood transmission. Impor­
tantly, both groups engaged in substantial risks related 
to sexual transmission of HIV. Almost half of respon­
dents in our study were former IDUs, showing that this 
group may contribute significantly to HIV transmission.
Injecting drug use is the main factor driving the HIV- 
epidemic in Indonesia. In a large cohort of HIV patients 
in our setting, two thirds had a history of IDU [19]. In 
line with this finding, the prevalence of HIV-infection 
among fIDUs and cIDUs in this study was high (66% 
respectively 60%), similar or slightly higher compared
with previous local and national data [4]. The prevalence 
of AIDS was higher among fIDUs; concern about their 
general health or the development of AIDS may cause 
them to move from injecting drugs [6].
Injecting with needles or syringe from other people 
(15%) or from shared disposal/sharps containers without 
bleaching (9%) was reported by a substantial proportion 
of IDUs, although lower compared to previous research 
in Indonesia (24% - 80%) [5,20]. The high rate of needle 
stick injuries is no surprise given the fact 40% of IDUs 
fail to discard used needles safely [21]. Risk related to 
injecting drugs was especially high in cIDUs, but fIDUs 
are experience certain things (e.g. needle sticks or shar­
ing of injecting equipment) which may have a low risk 
of HIV-transmission, but which may pose a significiant 
risk of transmitting HCV. This is important, as the pre­
valence of HCV is very high among IDUs in this setting; 
among 633 HIV patients with a history of IDU 87.7% 
were HCV-infected [19].
Both among current and former IDUs, sexual risk 
behavior may contribute significantly to HIV transmis­
sion. Sexual risk behavior was equally high in both 
groups, which is in contrast with previous studies 
reporting associations between injecting drug use and 
unsafe sex [22,23]. Condom use among IDUs has found 
to be inconsistent and especially low with sex workers 
and other risk groups for HIV transmission [20]. As 
IDUs often have multiple sex partners, including sex 
workers, HIV transmission may easily spread to people 
outside the IDU community.
Heroin was the most frequently used drug among IDUs 
in this sample but many reported use of cannabis, benzo­
diazepines and alcohol as well, in line with reports from 
China, Thailand, Ukraine, Lithuania, and Poland [24].
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The use of methadone or buprenorphine among cIDUs 
was higher compared to fIDUs. The EuropASI question­
naire does not allow us to verify whether this was as part 
of substitution treatment or not. Both drugs are officially 
registered in Indonesia for substitution treatm ent but 
illegal use is quite common. Buprenorphine injection has 
been reported in many countries including Indonesia, 
and can be regarded as a response to inadequate care, 
rather than simply as misuse [25].
Alcohol abuse was common, and was associated with 
risky sexual behavior, as has been reported previously 
[26]. The same has been reported for methamphetamine 
and amphetamine use [27], but this seems still relatively 
rare in this setting. Our study also showed a high preva­
lence of tattooing and piercing in former and current 
IDUs, both of which have may lead to transmission of 
HIV and viral hepatitis [8,9,28].
This study suffers form the limitations of a cross-sec­
tional study in a population which is difficult to reach, 
and the question is therefore how representative the 
samples are. By using RDS, we tried to minimize this 
risk [12,29]. Numerical simulations have shown that the 
possible bias, even if the seeds are not drawn randomly, 
is extremely small (0.3%) for all sample sizes greater 
than 200 [12]. Still, some IDUs who are not in the social 
networks with these participants can not be recruited 
through respondent driven sampling [30].
Conclusions
In conclusion, this study from Indonesia shows that for­
mer IDUs, when compared to current IDUs, may have 
similar high HIV prevalence rates and high sexual risk 
behavior. Specific programs focusing on the reduction of 
sexual risk behavior are needed among former and cur­
rent IDUs, in order to prevent further transmission to 
the general community. Drug-use treatment and inter­
ventions that examine the relationship between drug use 
and sexuality should be conducted. In addition, earlier 
HIV treatment may lower transmission among IDUs by 
reducing the 'com m unity viral load '[31]. We have 
recently shown that patients with a history of injecting 
drug use in our setting have a similar clinical and virolo- 
gical response to anti-retroviral treatment compared to 
non-IDUs [19]. Finally, evidence-based prevention 
should also be targeted at schoolchildren and young 
adolescents as injecting drug use starts at an early age 
in this setting.
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